AI drug discovery leaders warn U.S. health funding cuts risk falling behind global rivals
Executives from Lila Sciences and NVIDIA told Fortune that the convergence of AI and biology could redefine global competitiveness for decades.
Comments 0
Log in to join the conversation.
No comments yet. Be the first to share your thoughts!